Abella, Michael B.

HRN: 23-74-90  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/30/2026
06/05/2026
IV
650mg
Q6
Urti
Checking Initial Appropriateness 
06/05/2026
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/05/2026
06/12/2026
PO
4.5ml
Q8hrs
Amoebiasis
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: